Brandywine Global Investment Management LLC Acquires 75,457 Shares of Humana Inc. $HUM

Brandywine Global Investment Management LLC raised its holdings in Humana Inc. (NYSE:HUM) by 31.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 313,859 shares of the insurance provider’s stock after purchasing an additional 75,457 shares during the quarter. Brandywine Global Investment Management LLC’s holdings in Humana were worth $80,389,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after buying an additional 106,030 shares during the last quarter. Capital International Investors lifted its holdings in shares of Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after purchasing an additional 1,008,514 shares in the last quarter. Pzena Investment Management LLC grew its holdings in shares of Humana by 1.0% during the 4th quarter. Pzena Investment Management LLC now owns 4,072,208 shares of the insurance provider’s stock valued at $1,043,015,000 after purchasing an additional 41,125 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Humana by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 3,184,569 shares of the insurance provider’s stock valued at $812,540,000 after purchasing an additional 23,732 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Truist Financial increased their price objective on shares of Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday, June 1st. Morgan Stanley upped their price target on shares of Humana from $217.00 to $249.00 and gave the stock an “underweight” rating in a report on Thursday. Zacks Research upgraded Humana from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 13th. Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Finally, Barclays upped their target price on Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fourteen have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $279.30.

Humana Stock Performance

NYSE HUM opened at $349.85 on Monday. The company has a market capitalization of $42.00 billion, a price-to-earnings ratio of 37.42, a PEG ratio of 2.00 and a beta of 0.76. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $351.88. The stock has a fifty day simple moving average of $248.43 and a 200 day simple moving average of $232.39.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business’s revenue was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts expect that Humana Inc. will post 9 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 1.0%. Humana’s dividend payout ratio is presently 37.86%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.